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1 Introduction
One of the major risks in the pregnancy of
a diabetic women is the higher prevalence of
neonatal problems. In the newborn period hy-
poglycemia, visceromegaly, polycythemia,hy-
perbilirubinemia and a characteristic aspect can
be typical features of children of diabetic
mothers, and their perinatal morbidity and
mortality is significantly increased [4, 6]. Mod-
ern management of pregnant diabetic women
tries to reach normoglycemia which ideally
should be achieved before conception but at
least immediately after the diagnosis of preg-
nancy [5,10]. It has been shown that normogly-
cemia for the full length of pregnancy can be
achieved [1] under optimal circumstances with
continuous modifications of the insulin dose
based on daily measurements of the blood glu-
cose levels by the trained patient and biweekly
controls by the physician.
Glycosylated hemoglobin (HbAl) serves as a
parameter for long-term assessment of the
mean blood glucose, but its value is limited by
the fact that during pregnancy an increased
number of young erythrocytes are released re-
sulting in false low measurements [2].
WEISS [12] was the first to emphasize the impor-
tance of an insulin determination in amniotic
fluid for the management of diabetes in preg-
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nancy. Because of the long half-life of insulin in
amniotic fluid a measurement of this parameter
can be considered another index for the long-
term diabetic control, and the same applies
for C-peptide which is formed in equimolar
amounts with insulin during the proteolytic
cleavage of proinsulin [3].
Our study was designed to determine which
of the three parameters (HbAl, amniotic fluid
insulin or C-peptide) has the best prognostic
power with regard to neonatal problems due to
maternal diabetes.
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2 Patients and methods and C-peptide (Byk Malinckrodt). The values
were assessed following the curves described
HbAl-concentrations were measured biweekly
 before [3] Thefe were no compiications from
in 57 pregnant diabetic women, 2 of which
 the amniocenteses. For counselling purposes we
belonged to White's class A, 24 were class Β
 used & risk f of Q 3o/0 [7]
12 class C and in 19 patients the severity of
diabetes was class D (n = 15) or more (n = 4). The newborns were evaluated routinely by the
We used the micr column method (PanChem, pediatricians according to their clinical presen-
Kleinwallstadt, FRG) because its handling is tation and glucose requirements post partum.
simple and the results obtained correlate well The minimum requirements for classifying a
with the HbAlc-determination according to the child as having "major symptoms" were hypo-
method of TRIVELLI [11]. Mean values were glycemia of less than 30mg% for more than 7
calculated from the measurements between the days and body weight above the 90th percentile.
30th and 40th week of pregnancy, and in those Most of these children had visceromegaly and/
patients in whom only a few values could be or hyperbilirubinemia, some exhibited increas-
obtained because of late registration. ed hematocrit values, cardiomyopathy or hypo-
' , , , , calcemia. One child suffered from respiratory
For normal control values we used the measure-
 distress drome Minor alterations in blood
ments in 72 non-diabetic patients after the 30th
 e leydg which coul(J be controlled b
week of pregnancy. In those patients a routine
 f nt meals were not considered
oral glucose tolerance test was performed and
venous blood was obtained at the same time
for HbAl-determination. Only HbAl values in
those patients were used whose 100 g glucose 3 Results
tolerance test was not pathologic according to
 The mean yalue of HbΑΙ-measurements of
the criteria of Ο SULLIVAN [9 . The HbAl meas-
 thoge ^ who had normal m oQTT ^
urements were performed between the 30th and ^
 +" ^ Qm ^  For e*aluation of
40th week of pregnancy and up to three days
 the-insulin and C-peptide levels in the
alter delivery.
 34th _ 3?th pregnancy weeks those values were
The present study includes pregnancies in which considered normal which corresponded to the
an amniocentesis between the 34th and 37th 99th percentile of a distribution derived from
week was consented to by the patient. This the concentration of these peptides in 275 non-
constitutes about 52% of the total number of diabetic pregnancies. These limits were found
diabetic pregnancies in our center during the to be 23 μυ/ml insulin and 3 ng/ml C-peptide
observation period from 1981 — 1984. Using (table I). The cut-off points of 18 μΐΐ/ml insulin
commercially available test kits we measured and 2.6 ng/ml C-peptide used in tables II and
amniotic fluid insulin (Serono, Freiburg, FRG) Ilia, b are derived from the mean values of
Table I. Predictability of neonatal morbidity in infants of diabetic mothers.
parameter limits children without major symptoms children with major symptoms specificity sensitivity
correctly low false elevated correctly elevated false low
insulin
C-peptide
HbAl
23 μυ/ml
18 μυ/ml
3 ng/ml
2,6 ng/ml
7,5%
96% (n
83% (n
88% (n
75% (n
77% (n
= 46)
= 40)
= 42)
= 36)
= 37)
4% (n =
17% (n =
12% (n =
25% (n =
23% (n =
2)
8)
6)
12)
11)
56% (n
78% (n
50% (n
50% (n
44% (n
= 5)
= 7)
= 4)
= 4)
= 4)
44% (n
22% (n
50% (n
50% (n
56% (n
= 4)
= 2)
= 4)
= 4)
= 5)
J.
96%
83%
88%
75%
77%
Perinat.
56%
78%
50%
50%
44%
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Table II. Prediction of a healthy child and of major symptoms.
Prediction of a healthy child Prediction of major symptoms
parameter
insulin
C-peptide
HbAl
limit
23 μυ/ml
18 μυ/ml
3 ng/ml
2,6 ng/ml
7,5%
proportion of
normal values*
46/50
40/42
42/46
36/40
37/42
predictive
value
92%
95%
91%
90%
88%
limit
18 μυ/ml
23 μυ/ml
3 ng/ml
2,6 ng/ml
7,5%
9%
proportion
of elevated
values**
7/15
5 /7
4/10
4/16
4/15
4/ 9
predictive
value
47%
72%
40%
25%
27%
44%
* ratio of correctly diagnosed normal values over total of normal values
** ratio of correctly diagnosed elevated values over total of elevated values
Table Ilia. Prediction of a healthy child based on more
than one parameter.
condition correct predictive
prediction* value
insulin below 18 μυ/ml
and HbAl below 7,5% 29/30 97%
insulin below 18 μυ/ml,
HbAl below 7,5% and
C-peptide below 3 ng/ml 28/28 100%
insulin below 18 μυ/ml and
C-peptide below 3 ng/ml 35/37 95%
Table mb. Prediction of major symptoms based on
more than one parameter.
condition correct predictive
prediction* value
insulin above 18 μυ/ml
and HbAl above 7.5% 3/ 5
insulin above 18 μυ/ml and
C-peptide above 3 ng/ml 4/ 7
insulin above 18 μυ/ml,
C-peptide above 3 ng/ml
60%
57%
and HbAl above 7.5%
insulin above 23 μυ/ml,
C-peptide above 3 ng/ml
and HbAl above 7.5%
2 of 3 parameters above
limit (18 μυ/ml, 3 ng/ml,
7.5%)
21 3
21 3
6/11
66%
66%
54%
* number of correctly predicted cases over total of cases
fulfilling conditions
those concentrations found in healthy children
of diabetic mothers. The rate of correct predict-
ions is given in the tables.
Nine of the 57 children whose mothers had a
determination of glycosylated hemoglobin and
an amniocentesis, had major neonatal compli-
cations. The mean glucose application in those
children during the first 24 hours was 7.8 mg/
kg body weight/minute as opposed to 4.2 mg
in healthy children of diabetic mothers.
4 Discussion
Table I indicates that 75-96% of the children
without neonatal symptomatology had normal
values of one of the three parameters, depend-
ing on the cut-off points chosen. The narrower
the normal range is defined, the lower is the
number of children with normal values. If the
insulin cut-off point is lowered from 23 to
18 μΐΐ/ml, the percentage of children with nor-
mal values of amniotic fluid insulin decreases
from 96 to 83%. C-peptide shows a similar
decrease of normal values in non-symptomatic
patients from 88 to 75%. The rate of values
measured correctly as elevated increases from
56 to 78% in the case of insulin.
In the case of C-peptide the introduction of a
lower limit increases the rate of false low values,
the rate of correctly or falsely increased values
remains unchanged. We conclude from our data
J. Perinat. Med. 14 (1986)
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that the upper limits of the three parameters
should be 7.5% for HbAl, 18 μΠ/ml for amni-
otic fluid insulin and 3.0 ng/ml for C-peptide.
When trying to derive a prognosis from these
elevated values and to test the predictive value
of all three parameters, the results in table II
have to be considered. It is obvious that the
prediction of a healthy baby is easy. Depending
on the parameter chosen a correct prediction
can be expected in 83 to 95% of all cases.
The determination of amniotic fluid insulin is
associated with a predictive value based on
an upper limit of 18 μυ/ml. The prediction of
newborn morbidity can also be achieved using
the same criteria. For this purpose the determi-
nation of amniotic fluid insulin is most useful
with values higher than 23 μυ/ml being clearly
pathologic. The determination of C-peptide and
HbAl is less useful but values higher than 9%
HbAl can be considered pathologic in 44% of
the cases.
Taking into account more than one single para-
meter, the accuracy of the prediction "healthy
child" reaches 100% (table Ilia, b). The accu-
racy of the prediction of major neonatal prob-
lems cannot be further increased, it ranges be-
tween 54 and 66% if all three parameters are
assessed simultaneously. It should be taken into
account that the significance of the results is
limited due to the sample size.
According to our results the concentration of
insulin in amniotic fluid is the most reliable
parameter for the evaluation of developing fetal
impairment. This is in contrast to LIN et al [8],
who found C-peptide to be more reliable. It is
obvious that a statement can be made with
much higher certainty when the other para-
meters are also taken into account. For the
exclusion of severe neonatal disease HbAl, am-
niotic fluid insulin and C-peptide have to be
lower than 7.5%, 18 μυ/ml and 3.0 ng/ml re-
spectively. If two of these three parameters are
below these limits, a fetal impairment can be
excluded with more than 90% certainty.
An amniotic fluid insulin level of more than
23 μΠ/ηιΙ can be considered as a strong indica-
tor of neonatal disease. The accuracy of this
prediction is more than 70%. An increase of
the insulin level to more than 18 μυ/ml has to
be evaluated by taking the other parameters
into account: A fetal compromise has to be
assumed in more than 60% of the cases if all
three values are increased. If only two values*
are elevated, the accuracy of the prediction is
lowered to about 50%.
Summary
The predictive value of three parameters (amniotic fluid
insulin and C-peptide, and HbAl) in prognosticating
major neonatal symptomatology was investigated in 57
pregnancies of diabetic women. The prediction of a
healthy neonate can be achieved with a 90% accuracy
by measurement of the amniotic fluid insulin alone.
The correct prognosis for a child with major neonatal
problems due to maternal diabetes can be made with
70% certainty using the same method. All other para-
meters can be judged less valuable based on our results.
By using more than one of those parameters mentioned,
the prediction of a healthy child can be made more
correctly with a certainty of almost 100%. The accuracy
in predicting a child with major symptoms cannot be
increased any further.
Keywords: Amniotic fluid C-peptide, amniotic fluid insulin, HbAl, infants of diabetic mothers.
Zusammenfassung
Antenatale Vorhersage des Neugeborenenzustandes bei
schwangeren Diabetikerinnen
In 57 Schwangerschaften von Diabetikerinnen wurde der
pr diktive Wert dreier Parameter: Fruchtwasser-Insulin,
Fruchtwasser-C-Peptid und HbAl untersucht. Die Vor-
hersage eines gesunden Neugeborenen ist durch die Be-
stimmung des Fruchtwasserinsulingehaltes mit einer Si-
cherheit von ber 90% m glich, die eines Kindes mit
J. Perinat. Med. 14 (1986)
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ausgeprägter diabetischer Fetopathie jedoch nur mit
70%iger Sicherheit. Bei den anderen Parametern ist der
prädiktive Wert geringer.
Durch die gleichzeitige Wertung mehrerer der obenge-
nannten Parameter kann die Zuverlässigkeit der Vorher-
sage eines gesunden Kindes auf nahezu 100% gesteigert
werden, die Vorhersage eines kranken Kindes wird nicht
sicherer als durch die Bestimmung von Fruchtwasserin-
sulin allein.
Schlüsselwörter: Diabetische Fetopathie, Fruchtwasser-C-Peptid, Fruchtwasserinsulin, HbAl.
Resume
Estimation antenatale du devenir fetal chez les diabeti-
ques enceintes
On a explore la valeur predictive de trois parametres
(insuline dans le liquide amniotique, peptide C et Hb Al)
face ä la Symptomatologie neonatale majeure au cours
de 57 grossesses chez des femmes diabetiques. On peut
prevoir un nouveau-ne en bonne sante avec une fiabilite
de 90% en determinant uniquement I'insuline dans le
liquide amniotique. La prevision correcte d'un enfant
qui presentera des problemes neonataux majeurs se-
condaires au diabete maternel est possible avec une
fiabilite de 70% en utilisant la meme methode. En se
fondant sur nos resultats, on peut juger tous les autres
parametres comme moins valables.
En utilisant plus d'un des parametres meiitionnes, on
peut predire correctement un enfant en bonne sante avec
une fiabilite proche de 100%. Toutefois, la fiabilite de
la prevision d'un enfant qui presentera des symptomes
majeurs, ne peut pas etre augmente de la sorte.
Mots-cles: Enfants de meres diabetiques, HbAl, insuline dans le liquide amniotique, peptides C du liquide
amniotique.
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